Dan Hesse

2.5k total citations · 1 hit paper
33 papers, 989 citations indexed

About

Dan Hesse is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dan Hesse has authored 33 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dan Hesse's work include Multiple Sclerosis Research Studies (14 papers), Diabetes Treatment and Management (10 papers) and Metabolism, Diabetes, and Cancer (9 papers). Dan Hesse is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Diabetes Treatment and Management (10 papers) and Metabolism, Diabetes, and Cancer (9 papers). Dan Hesse collaborates with scholars based in Denmark, United States and Israel. Dan Hesse's co-authors include Per Soelberg Sørensen, Finn Sellebjerg, Martin Krakauer, Helle Bach Søndergaard, Rasmus Sørrig, Silva Arslanian, Aaron S. Kelly, Daniel Weghuber, Lucy D. Mastrandrea and Ole Kleist Jeppesen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Dan Hesse

32 papers receiving 971 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-Weekly Semaglutide in Adolescents with Obesity

2022 338 citations Daniel Weghuber, Timothy Barrett et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Hesse Denmark	15	316	244	223	203	177	33	989
Natalia Wawrusiewicz‐Kurylonek Poland	20	74 0.2×	194 0.8×	156 0.7×	273 1.3×	68 0.4×	73	991
C. E. Fiore Italy	19	243 0.8×	267 1.1×	134 0.6×	68 0.3×	200 1.1×	48	1.2k
Cathy Zhao Australia	20	212 0.7×	114 0.5×	88 0.4×	182 0.9×	70 0.4×	46	1.1k
Teresa G. Hayes United States	20	63 0.2×	418 1.7×	111 0.5×	190 0.9×	228 1.3×	44	1.3k
Keith Byron Australia	15	95 0.3×	154 0.6×	60 0.3×	95 0.5×	127 0.7×	32	786
Amanda M. Shearman United States	16	104 0.3×	502 2.1×	408 1.8×	61 0.3×	146 0.8×	18	1.3k
Karen Siu Ling Lam Hong Kong	18	116 0.4×	465 1.9×	337 1.5×	139 0.7×	71 0.4×	34	1.2k
Richard Pang China	19	97 0.3×	324 1.3×	385 1.7×	58 0.3×	103 0.6×	45	1.1k
Filipe Palavra Portugal	12	592 1.9×	147 0.6×	50 0.2×	85 0.4×	154 0.9×	44	921
Yincheng Teng China	17	119 0.4×	222 0.9×	210 0.9×	137 0.7×	77 0.4×	55	922

Countries citing papers authored by Dan Hesse

Since Specialization

Citations

This map shows the geographic impact of Dan Hesse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Hesse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Hesse more than expected).

Fields of papers citing papers by Dan Hesse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Hesse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Hesse. The network helps show where Dan Hesse may publish in the future.

Co-authorship network of co-authors of Dan Hesse

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Hesse. A scholar is included among the top collaborators of Dan Hesse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Hesse. Dan Hesse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poulsen, Casper Sahl, Dan Hesse, Gabriel da Rocha Fernandes, et al.. (2024). Characterization of the gut bacterial and viral microbiota in latent autoimmune diabetes in adults. Scientific Reports. 14(1). 8315–8315. 2 indexed citations

Kelly, Aaron S., Silva Arslanian, Dan Hesse, et al.. (2023). Reducing BMI below the obesity threshold in adolescents treated with once‐weekly subcutaneous semaglutide 2.4 mg. Obesity. 31(8). 2139–2149. 24 indexed citations

Kabir, Ali, Daniel Weghuber, Timothy Barrett, et al.. (2023). ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE 2.4 MG IN ADOLESCENTS WITH OVERWEIGHT OR OBESITY. Canadian Journal of Diabetes. 47(7). S181–S182.

Kushner, Robert F., W. Timothy Garvey, Dan Hesse, et al.. (2022). Abstract 9: Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1). Indian Journal of Endocrinology and Metabolism. 26(Suppl 1). S9–S9. 1 indexed citations

Weghuber, Daniel, Timothy Barrett, Margarita Barrientos‐Pérez, et al.. (2022). Once-Weekly Semaglutide in Adolescents with Obesity. New England Journal of Medicine. 387(24). 2245–2257. 338 indexed citations breakdown →

Kushner, Robert F., W. Timothy Garvey, Dan Hesse, et al.. (2021). Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1). Journal of the Endocrine Society. 5(Supplement_1). A24–A24. 9 indexed citations

Petri, Kristin C. Carlsson, Paula M. Hale, Dan Hesse, Naveen Rathor, & Lucy D. Mastrandrea. (2021). Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity. Pediatric Obesity. 16(10). e12799–e12799. 11 indexed citations

Börnsen, Lars, Jeppe Romme Christensen, Rikke Ratzer, et al.. (2015). Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis. PLoS ONE. 10(3). e0118830–e0118830. 17 indexed citations

Lund, Henrik Hautop, Martin Krakauer, Arnold Skimminge, et al.. (2013). Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis. PLoS ONE. 8(2). e56375–e56375. 26 indexed citations

10.

Sellebjerg, Finn, Martin Krakauer, Dan Hesse, et al.. (2012). Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis. PLoS ONE. 7(6). e35927–e35927. 13 indexed citations

11.

Christensen, Jeppe Romme, Lars Börnsen, Dan Hesse, et al.. (2012). Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. Journal of Neuroinflammation. 9(1). 215–215. 68 indexed citations

12.

Sellebjerg, Finn, Dan Hesse, Henrik Hautop Lund, et al.. (2012). Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis. Multiple Sclerosis Journal. 19(2). 179–187. 25 indexed citations

13.

Sellebjerg, Finn, Chris Juul Hedegaard, Martin Krakauer, et al.. (2011). Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis. Multiple Sclerosis Journal. 18(3). 305–313. 19 indexed citations

14.

Hesse, Dan, Pia Ekbom, U. Hesse, et al.. (2010). Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes. Diabetes Research and Clinical Practice. 89(1). 16–21. 10 indexed citations

15.

Hesse, Dan, Martin Krakauer, Henrik Hautop Lund, et al.. (2010). Disease protection and interleukin‐10 induction by endogenous interferon‐β in multiple sclerosis?. European Journal of Neurology. 18(2). 266–272. 38 indexed citations

16.

Sellebjerg, Finn, Martin Krakauer, Dan Hesse, et al.. (2009). Identification of new sensitive biomarkers for the in vivo response to interferon‐β treatment in multiple sclerosis using DNA‐array evaluation. European Journal of Neurology. 16(12). 1291–1298. 42 indexed citations

17.

Søndergaard, Helle Bach, Martin Krakauer, Dan Hesse, Per Soelberg Sørensen, & Finn Sellebjerg. (2009). F.73. Expression Profiling of Blood Mononuclear Cells from Patients with Multiple Sclerosis Identifies Differentially Expressed miRNAs and Their mRNA Targets. Clinical Immunology. 131. S113–S113. 1 indexed citations

18.

Hesse, Dan, Jette Lautrup Frederiksen, Nils Koch‐Henriksen, et al.. (2008). Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon‐β. European Journal of Neurology. 16(1). 43–47. 13 indexed citations

19.

Hesse, Dan & Per Soelberg Sørensen. (2007). Using measurements of neutralizing antibodies: the challenge of IFN‐β therapy. European Journal of Neurology. 14(8). 850–859. 34 indexed citations

20.

Hesse, Dan, et al.. (2004). [The effect of soluble dietary fibers on glycemic regulation and lipid status in patients with type 2 diabetes mellitus].. PubMed. 166(20). 1899–902. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact